Combining the evidence that Brf1 dysregulation promoted the development of HCC and that abnormal apoptosis promoted the development of HCC, we speculated that Brf1 promoted the development of HCC through inhibition of apoptosis. The gene discussed is BRF1; the disease is hepatocellular carcinoma.